Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ORIC
ORIC
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ORIC News
Pomerantz LLP Investigates Securities Fraud Claims Against ORIC Pharmaceuticals
1d ago
Globenewswire
Pomerantz Investigates ORIC Pharmaceuticals for Securities Fraud
May 01 2026
PRnewswire
Pomerantz LLP Investigates ORIC Pharmaceuticals for Securities Fraud
Apr 28 2026
Globenewswire
Pomerantz LLP Investigates Securities Fraud Claims Against ORIC Pharmaceuticals
Apr 21 2026
Globenewswire
US Stocks Close Higher Amid Optimism Over Middle East Conflict Resolution
Apr 01 2026
NASDAQ.COM
Oric Pharmaceuticals Shares Plunge 28% Amid Safety Concerns
Apr 01 2026
stocktwits
US Stocks Rise on Optimism Over Middle East Conflict Resolution
Apr 01 2026
NASDAQ.COM
US Stocks Rise on Optimism Over Middle East Conflict Resolution
Apr 01 2026
NASDAQ.COM
Oric Pharmaceuticals Reports New Rinzimetostat Developments
Apr 01 2026
NASDAQ.COM
ORIC Pharmaceuticals Shares Drop After Rinzimetostat Trial Data Release
Apr 01 2026
seekingalpha
ORIC Pharmaceuticals Faces Safety Concerns in Drug Trial
Apr 01 2026
stocktwits
ORIC Pharmaceuticals to Report New Drug Trial Data
Mar 27 2026
Newsfilter
BETA Technologies Reports Disappointing Q4 Results
Mar 09 2026
Benzinga
Lisata Therapeutics to be Taken Private by Kuva Labs
Mar 09 2026
Benzinga
U.S. Stock Futures Decline as Methanex Reports Disappointing Earnings
Mar 06 2026
Benzinga
ORIC Pharmaceuticals Reports Narrower Q4 Loss
Feb 24 2026
NASDAQ.COM
Show More News
